Effects of nanocurcumin on inflammatory factors and clinical outcomes in critically ill patients with sepsis: A pilot randomized clinical trial

Effects of nanocurcumin on inflammatory factors and clinical outcomes in critically ill patients with sepsis: A pilot randomized clinical trial


چاپ صفحه
پژوهان
صفحه نخست سامانه
چکیده مقاله
چکیده مقاله
نویسندگان
نویسندگان
دانلود مقاله
دانلود مقاله
دانشگاه علوم پزشکی تبریز
دانشگاه علوم پزشکی تبریز

نویسندگان: علی طریقت اسفنجانی , عطا محمودپور , آرش کریمی , فاطمه کوشکی

کلمات کلیدی: Sepsis Curcumin Critical illness Organ dysfunction Inflammatory factors Randomised controlled trial

نشریه: 55149 , 101122 , 36 , 2020

اطلاعات کلی مقاله
hide/show

نویسنده ثبت کننده مقاله علی طریقت اسفنجانی
مرحله جاری مقاله تایید نهایی
دانشکده/مرکز مربوطه مرکز تحقیقات علوم تغذیه
کد مقاله 73242
عنوان فارسی مقاله Effects of nanocurcumin on inflammatory factors and clinical outcomes in critically ill patients with sepsis: A pilot randomized clinical trial
عنوان لاتین مقاله Effects of nanocurcumin on inflammatory factors and clinical outcomes in critically ill patients with sepsis: A pilot randomized clinical trial
ناشر 6
آیا مقاله از طرح تحقیقاتی و یا منتورشیپ استخراج شده است؟ بلی
عنوان نشریه (خارج از لیست فوق)
نوع مقاله Original Article
نحوه ایندکس شدن مقاله ایندکس شده سطح یک – ISI - Web of Science
آدرس لینک مقاله/ همایش در شبکه اینترنت

خلاصه مقاله
hide/show

Introduction: Sepsis is a severe reaction and excessive immune response to infection, which can lead to tissue damage, organ dysfunction, and death. This study aimed to investigate the protective effect of curcumin on inflammatory factors and clinical outcomes in patients with sepsis. Methods: This randomized clinical trial was conducted on 40 patients with sepsis aged 18–55 years, who received 160 mg of nanocurcumin supplement (two capsules 80 mg) or placebo (two capsules of placebo) via a nasogastric tube for 10 days. Sequential organ failure assessment (SOFA) was evaluated on days 1 and 10. Serum levels of inflammatory factors of procalcitonin (PCT), Interleukin- 6 (IL-6), tumor necrosis factor-alpha, (TNF- α),and high-sensitive C-reactive protein (hs-CRP) were measured before the beginning of the intervention and on days 5 and 10. Length of hospital stay, mortality rate, and mechanical ventilation duration was compared between groups. Results: Serum levels of PCT (p=0.002), IL-6 (p=0.012), and TNF-α (p=0.026) in the nanocurcumin group on day 10 were significantly lower than the placebo group. The duration of mechanical ventilation in the nanocurcumin group was remarkably (p=0.038) lower than the placebo group. Also, the SOFA score significantly (p=0.005) decreased in the intervention group compared to the placebo group. No significant difference was observed in the mean serum levels of hs-CRP, duration of the intensive care unit stay, and mortality rates between the study groups. Conclusions: Our study indicated that nanocurcumin could decrease the levels of inflammatory factors, duration of mechanical ventilation, and organ failure in critically ill patients.

نویسندگان
hide/show

نویسنده نفر چندم مقاله
علی طریقت اسفنجانیششم
عطا محمودپوردوم
آرش کریمیاول
فاطمه کوشکیسوم

لینک دانلود مقاله
hide/show

نام فایل تاریخ درج فایل اندازه فایل دانلود
karimi2020.pdf1399/05/261050651دانلود